S.Biomedics Co., Ltd. (KOSDAQ:304360)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Medical Devices	13.59B
Medical Devices Growth	4.34%
Stem Cell Therapy	655.24M
Stem Cell Therapy Growth	125.17%
Consolidated Adjustment	-515.69M
Consolidated Adjustment Growth	143.52%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Overseas	11.38B
Overseas Growth	1.48%
South Korea	2.35B
South Korea Growth	24.30%